Company profile

FaceHeart

Remote Patient Monitoring & Wearables

Company profile

About FaceHeart

FaceHeart is a medical technology company that has developed FDA-cleared contactless video-based vital signs measurement software powered by AI image recognition technology. The company's flagship product, FaceHeart Vitals™, is the first video-based vital sign solution to receive US FDA 510(k) clearance as a Class II Software as Medical Device (SaMD), with clearances for both heart rate (K223622) and respiratory rate (K243966). Using remote photoplethysmography (rPPG) technology, FaceHeart analyzes subtle color changes in facial skin caused by blood circulation to measure key health metrics in real-time through a standard camera. The platform can measure 15+ health parameters including heart rate, respiratory rate, blood pressure, oxygen saturation, heart rate variability, atrial fibrillation detection, stress index, cardiovascular age, and various wellness indicators—all within a 50-second facial scan. FaceHeart serves multiple market segments including mobile health applications, insurance companies, telehealth providers, corporate wellness programs, and smart mirror manufacturers. The company's SDK can be integrated into smartphones, tablets, computers, smart home devices, and embedded boards, supporting both cloud-based and edge computing deployments. The technology is designed to work contactlessly from 30-150 cm away, allowing users to keep makeup and glasses on during measurements. With validation backed by 20+ clinical trials and 300M+ data points, FaceHeart aims to democratize healthcare access by enabling anyone, anywhere to access vital health insights through everyday devices.

Company description FaceHeart official website

Primary marketRemote Patient Monitoring & Wearables
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at FaceHeart?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Atrial fibrillation screening
  • Cardiovascular health monitoring
  • General wellness and stress management
  • Heart failure risk
  • Hypertension
  • Preeclampsia risk assessment

Who it serves

  • Corporate wellness programs
  • Insurance companies
  • Mobile health app developers
  • Smart device manufacturers
  • Telehealth providers

Deployment & integration

Api Only · Cloud Saas · Embedded deployment with recorded integration context.

Recorded integration context: FHIR-formatted data output for healthcare system integration.

Geographic context

MarketsGlobal · Latin America · Mongolia · Peru · United States
Company sourceOfficial website

Company milestones

Platform expansion

First FDA-cleared contactless video-based vital sign solution; FDA 510(k) clearances obtained for heart rate (K223622) and respiratory rate (K243966); First company in Peru and Latin America to deploy FDA-cleared AI vital signs technology; Partnership with Emagine Solutions for maternal health monitoring

Partnerships

Recorded partners

  • Agula Insurtech (Mongolia)
  • Emagine Solutions (The Journey Pregnancy app)
  • Grupo Red Salud (Peru/Latin America)

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

FaceHeart App

Track your health trend on your smartphone with contactless vital signs

Software · Cloud SaaSCompany source

FaceHeart CardioMirror

Check your heart with just a glance through smart mirror technology

Device · EmbeddedCompany source

FaceHeart Vitals SDK

FDA-cleared contactless vital signs measurement SDK powered by AI image recognition

Software · Api OnlyCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

No linked records are currently available.

Clinical validation

Clinical-trial records

No linked records are currently available.

Regulatory

Regulatory records

FaceHeart Vitals Software Development Kit (FH vitals SDK)

K223622 · 510k · Sep 1, 2023

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

FDA-cleared accuracy

Heart rate and respiratory rate measurements validated for clinical use

15+ health metrics

Comprehensive health assessment from single 50-second scan

Contactless measurement

No wearables or physical contact required, 30-150 cm distance

Agula Insurtech

AI-driven contactless vital sign measurement for health monitoring of employees in human resource management, identifying health indicators that impact productivity

Enabled proactive health management for stable growth and operational efficiency

Emagine Solutions Technology (The Journey Pregnancy app)

Integrating FaceHeart into The Journey Pregnancy app to enable patients to track blood pressure trends digitally without equipment, helping assess propensity for preeclampsia and hypertensive conditions

Closed access gap in maternal health for patients without home blood pressure monitoring equipment

Grupo Red Salud

First company in Peru and Latin America to utilize FDA-cleared AI technology for contactless vital signs, driving innovative solutions to democratize healthcare across the region

Enhanced quality of care and advanced telemedicine throughout Latin America

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Ivan Vasquez Rojas

CEO

Dolgor D.

Co-Founder and CEO

06 · Company updates

Updates from FaceHeart

Recent articles published on FaceHeart's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Remote Patient Monitoring & Wearables

Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon